+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global TNF Inhibitors Market by Product (Biosimilars, Cimzia, Enbrel), Application (Ankylosing Spondylitis, Crohn's Disease, Hidradenitis Suppurativa) - Forecast 2024-2030

  • PDF Icon

    Report

  • 199 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889546
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The TNF Inhibitors Market size was estimated at USD 33.84 billion in 2023, USD 36.15 billion in 2024, and is expected to grow at a CAGR of 6.92% to reach USD 54.06 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the TNF Inhibitors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the TNF Inhibitors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the TNF Inhibitors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alkem Laboratories Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Cadila Healthcare Ltd., Cipla Ltd., Dr Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Janssen Pharmaceuticals, Johnson & Johnson Services, Inc., Lupin Ltd., Macleods Pharmaceuticals Pvt. Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Ranbaxy Laboratories Limited, Reliance Life Sciences, Roche Products India Pvt Ltd., Samsung Bioepis NL B.V., Sanofi S.A., Torrent Pharmaceuticals Ltd., and UCB Inc.

Market Segmentation & Coverage

This research report categorizes the TNF Inhibitors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Biosimilars
    • Cimzia
    • Enbrel
    • Humira
    • Remicade
    • Simponi/Simponi Aria
  • Application
    • Ankylosing Spondylitis
    • Crohn’s Disease
    • Hidradenitis Suppurativa
    • Juvenile Idiopathic Arthritis
    • Psoriasis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Ulcerative Colitis
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the TNF Inhibitors Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the TNF Inhibitors Market?
  3. What are the technology trends and regulatory frameworks in the TNF Inhibitors Market?
  4. What is the market share of the leading vendors in the TNF Inhibitors Market?
  5. Which modes and strategic moves are suitable for entering the TNF Inhibitors Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. TNF Inhibitors Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of autoimmune diseases
5.1.1.2. Increasing healthcare expenditure and development in diagnostic techniques
5.1.2. Restraints
5.1.2.1. Adverse health effects and risk of infections associated with the use of TNF inhibitors
5.1.3. Opportunities
5.1.3.1. Advancements in biotechnology and development of new and improved TNF inhibitors
5.1.3.2. Growing application in treatment of diverse medical conditions such as cancer
5.1.4. Challenges
5.1.4.1. Availability of alternative treatment options for autoimmune disease
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. TNF Inhibitors Market, by Product
6.1. Introduction
6.2. Biosimilars
6.3. Cimzia
6.4. Enbrel
6.5. Humira
6.6. Remicade
6.7. Simponi/Simponi Aria
7. TNF Inhibitors Market, by Application
7.1. Introduction
7.2. Ankylosing Spondylitis
7.3. Crohn’s Disease
7.4. Hidradenitis Suppurativa
7.5. Juvenile Idiopathic Arthritis
7.6. Psoriasis
7.7. Psoriatic Arthritis
7.8. Rheumatoid Arthritis
7.9. Ulcerative Colitis
8. Americas TNF Inhibitors Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific TNF Inhibitors Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa TNF Inhibitors Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Alkem Laboratories Ltd.
12.1.3. Amgen Inc.
12.1.4. Boehringer Ingelheim International GmbH
12.1.5. Bristol Myers Squibb
12.1.6. Cadila Healthcare Ltd.
12.1.7. Cipla Ltd.
12.1.8. Dr Reddy's Laboratories Ltd.
12.1.9. Emcure Pharmaceuticals Ltd.
12.1.10. Glenmark Pharmaceuticals Ltd.
12.1.11. Intas Pharmaceuticals Ltd.
12.1.12. Janssen Pharmaceuticals
12.1.13. Johnson & Johnson Services, Inc.
12.1.14. Lupin Ltd.
12.1.15. Macleods Pharmaceuticals Pvt. Ltd.
12.1.16. Merck KGaA
12.1.17. Novartis AG
12.1.18. Pfizer Inc.
12.1.19. Ranbaxy Laboratories Limited
12.1.20. Reliance Life Sciences
12.1.21. Roche Products India Pvt Ltd.
12.1.22. Samsung Bioepis NL B.V.
12.1.23. Sanofi S.A.
12.1.24. Torrent Pharmaceuticals Ltd.
12.1.25. UCB Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. TNF INHIBITORS MARKET RESEARCH PROCESS
FIGURE 2. TNF INHIBITORS MARKET SIZE, 2023 VS 2030
FIGURE 3. TNF INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TNF INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TNF INHIBITORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TNF INHIBITORS MARKET DYNAMICS
FIGURE 7. TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES TNF INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES TNF INHIBITORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. TNF INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. TNF INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. TNF INHIBITORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TNF INHIBITORS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TNF INHIBITORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. TNF INHIBITORS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TNF INHIBITORS MARKET SIZE, BY CIMZIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TNF INHIBITORS MARKET SIZE, BY ENBREL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TNF INHIBITORS MARKET SIZE, BY HUMIRA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. TNF INHIBITORS MARKET SIZE, BY REMICADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TNF INHIBITORS MARKET SIZE, BY SIMPONI/SIMPONI ARIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. TNF INHIBITORS MARKET SIZE, BY ANKYLOSING SPONDYLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TNF INHIBITORS MARKET SIZE, BY CROHN’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. TNF INHIBITORS MARKET SIZE, BY HIDRADENITIS SUPPURATIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. TNF INHIBITORS MARKET SIZE, BY JUVENILE IDIOPATHIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. TNF INHIBITORS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. TNF INHIBITORS MARKET SIZE, BY PSORIATIC ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. TNF INHIBITORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. TNF INHIBITORS MARKET SIZE, BY ULCERATIVE COLITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28. CANADA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. CANADA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. MEXICO TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. MEXICO TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES TNF INHIBITORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. CHINA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. CHINA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. INDIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. INDIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. INDONESIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. INDONESIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. JAPAN TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. JAPAN TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MALAYSIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. MALAYSIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. PHILIPPINES TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. PHILIPPINES TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. SINGAPORE TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. SINGAPORE TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. SOUTH KOREA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. SOUTH KOREA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. TAIWAN TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. TAIWAN TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. THAILAND TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. THAILAND TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. VIETNAM TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. VIETNAM TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA TNF INHIBITORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. DENMARK TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. DENMARK TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. EGYPT TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. EGYPT TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. FINLAND TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. FINLAND TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. FRANCE TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. FRANCE TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. GERMANY TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. GERMANY TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. ISRAEL TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ISRAEL TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ITALY TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. ITALY TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. NETHERLANDS TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. NETHERLANDS TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. NIGERIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. NIGERIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. NORWAY TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. NORWAY TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. POLAND TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. POLAND TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. QATAR TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. QATAR TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. RUSSIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SAUDI ARABIA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. SAUDI ARABIA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. SOUTH AFRICA TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. SOUTH AFRICA TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. SPAIN TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. SPAIN TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. SWEDEN TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. SWEDEN TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. SWITZERLAND TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SWITZERLAND TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. TURKEY TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. TURKEY TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED ARAB EMIRATES TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM TNF INHIBITORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM TNF INHIBITORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. TNF INHIBITORS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 108. TNF INHIBITORS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 109. TNF INHIBITORS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb
  • Cadila Healthcare Ltd.
  • Cipla Ltd.
  • Dr Reddy's Laboratories Ltd.
  • Emcure Pharmaceuticals Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Janssen Pharmaceuticals
  • Johnson & Johnson Services, Inc.
  • Lupin Ltd.
  • Macleods Pharmaceuticals Pvt. Ltd.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Ranbaxy Laboratories Limited
  • Reliance Life Sciences
  • Roche Products India Pvt Ltd.
  • Samsung Bioepis NL B.V.
  • Sanofi S.A.
  • Torrent Pharmaceuticals Ltd.
  • UCB Inc.

Methodology

Loading
LOADING...

Table Information